Skin antiseptics used prior to intravascular catheter insertion.
The recent epic2 publication (Pratt et al, 2007) provides evidence-based guidelines for the prevention of healthcare-associated infections. One of the new recommendations related to the prevention of central venous catheter (CVC) associated infection states that 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol (IPA) should be used for cutaneous antisepsis prior to device insertion. This article reviews cutaneous antisepsis prior to intravascular catheter placement.
Adams
Debra
D
Microbiology Research and Development Group, University Hospital Birmingham NHS Foundation Trust, The Queen Elizabeth Hospital, Edgbaston, Birmingham.
Elliot
T S J
TS
D019840:2-Propanol / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002710:Chlorhexidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003428:Cross Infection / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004739:England / Q000453:epidemiology; D019317:Evidence-Based Medicine; D006801:Humans; D017053:Infection Control / Q000379:methods* / Q000592:standards; D011206:Povidone-Iodine / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D018805:Sepsis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D017592:Skin Care / Q000379:methods* / Q000592:standards
D000891:Anti-Infective Agents, Local; D011206:Povidone-Iodine; C010882:chlorhexidine gluconate; D019840:2-Propanol; D002710:Chlorhexidine